Related Experiment Videos
Decreased liver and lung drug-metabolizing activity in mice treated with Corynebacterium parvum
Abstract:
Injections of killed suspensions of Corynebacterium parvum (i.p.) in young male mice were followed by time- and dose-dependent decreases in the drug-metabolizing activity of liver microsomes and lung homogenates. In vitro assays with model substrates [aminopyrine, aniline, p-nitroanisole, and benzo(a)pyrene] were used to quantitate drug-metabolizing activity. It is likely that such decreases in mixed function oxidases activity will act to significantly alter the pharmacokinetics of concurrently or subsequently administered drugs. The results provide a possible mechanism to explain several previously reported immunochemotherapeutic interactions.
Insights
Corynebacterium parvum injections reduced drug metabolism in mice liver and lung tissues. This finding may explain interactions between immunotherapy and chemotherapy drugs.
Area of Science:
- Immunology
- Pharmacology
- Biochemistry
Background:
- Corynebacterium parvum is an immunomodulator.
- Drug metabolism is crucial for drug efficacy and toxicity.
- Immunochemotherapy interactions are complex and not fully understood.
Purpose of the Study:
- To investigate the effect of Corynebacterium parvum on drug-metabolizing enzymes.
- To explore a potential mechanism for observed immunochemotherapeutic interactions.
Main Methods:
- Young male mice received intraperitoneal injections of killed Corynebacterium parvum.
- Drug-metabolizing activity was assessed in liver microsomes and lung homogenates using in vitro assays.
- Model substrates including aminopyrine, aniline, p-nitroanisole, and benzo(a)pyrene were utilized.
Main Results:
- Injections of Corynebacterium parvum caused time- and dose-dependent decreases in drug-metabolizing activity.
- This reduction was observed in both liver microsomes and lung homogenates.
- Mixed function oxidases activity was significantly affected.
Conclusions:
- Corynebacterium parvum administration suppresses drug metabolism.
- This suppression can alter the pharmacokinetics of other drugs administered concurrently or subsequently.
- The study provides a potential mechanism for understanding immunochemotherapeutic interactions.